Denali Therapeutics Inc.



After Hours

 --Real time quotes

Mar 22, 2023, 4:10 p.m.





0.00 0.00%


Volume 31,633

Real time quotes


Today's close

$ 23.26

$ 22.58


-0.68 -2.92%

Day low

Day high




52 week low

52 week high




Annual Financials for Denali Therapeutics Inc.


Fiscal year is January-December. All values USD millions. 20182019202020212022 5-year trend
Cash & Short Term Investments 464.3M415.36M1.47B865.41M1.34B
Cash Only 77.12M79.45M507.14M293.48M218.04M
Short-Term Investments -----
Total Accounts Receivable 8.55M--14.93M5M
Accounts Receivables, Net 7.36M--13.7M5M
Accounts Receivables, Gross 7.36M--13.7M5M
Bad Debt/Doubtful Accounts -----
Other Receivables 1.18M--1.23M-
Inventories -----
Finished Goods -----
Work in Progress -----
Raw Materials -----
Progress Payments & Other -----
Other Current Assets 7.99M14.68M25.96M16.9M31.1M
Miscellaneous Current Assets 1.35M14.68M25.96M16.9M31.1M
Total Current Assets 480.84M430.03M1.5B897.23M1.37B
20182019202020212022 5-year trend
Net Property, Plant & Equipment 25.16M80.66M73.46M69.61M74.52M
Property, Plant & Equipment - Gross 37.17M92.93M94.27M98.95M111.74M
Buildings -----
Land & Improvements -----
Computer Software and Equipment 458,0001.16M1.25M1.34M1.61M
Other Property, Plant & Equipment 22.36M36M36.18M36.76M45.28M
Accumulated Depreciation 12.01M12.27M20.8M29.34M37.22M
Total Investments and Advances 149.38M41.39M34.2M426.95M1.5M
Other Long-Term Investments 149.38M41.39M34.2M426.95M1.5M
Long-Term Note Receivable -----
Intangible Assets -----
Net Goodwill -----
Net Other Intangibles -----
Other Assets 6.61M1.16M962,00010.37M11.9M
Tangible Other Assets 764,0001.16M962,00010.37M11.9M
Total Assets 661.98M553.23M1.6B1.4B1.46B

Liabilities & Shareholders' Equity

20182019202020212022 5-year trend
ST Debt & Current Portion LT Debt -3.67M4.69M5.45M7.32M
Short Term Debt -3.67M4.69M5.45M7.32M
Current Portion of Long Term Debt -----
Accounts Payable 1.89M2.59M1.07M4.78M2.79M
Income Tax Payable -----
Other Current Liabilities 30.9M39.09M65.94M368.01M353.81M
Dividends Payable -----
Accrued Payroll 9.95M8.74M20.5M19.01M17.09M
Miscellaneous Current Liabilities 20.94M30.35M45.44M349M336.73M
Total Current Liabilities 32.79M45.34M71.7M378.25M363.92M
Long-Term Debt -68.87M64.18M58.55M53.03M
Long-Term Debt excl. Capitalized Leases -----
Non-Convertible Debt -----
Convertible Debt -----
Capitalized Lease Obligations -----
Provision for Risks & Charges -----
Deferred Taxes -----
Deferred Taxes - Credit -----
Deferred Taxes - Debit -----
Other Liabilities 82.35M44.13M317.88M5.07M858,000
Other Liabilities (excl. Deferred Income) 25M379,000701,000379,000379,000
Deferred Income 57.35M43.75M317.17M4.69M479,000
Total Liabilities 115.14M158.34M453.75M441.87M417.81M
Non-Equity Reserves -----
Preferred Stock (Carrying Value) -----
Redeemable Preferred Stock -----
Non-Redeemable Preferred Stock -----
Common Equity (Total) 546.85M394.89M1.15B962.29M1.04B
Common Stock Par/Carry Value 1.27M1.29M1.53M1.55M1.69M
Retained Earnings (227.94M)(425.55M)(354.42M)(645M)(970.99M)
ESOP Debt Guarantee -----
Cumulative Translation Adjustment/Unrealized For. Exch. Gain -----
Unrealized Gain/Loss Marketable Securities (649,000)350,000(245,000)(2.5M)(6.89M)
Revaluation Reserves -----
Treasury Stock -----
Total Shareholders' Equity 546.85M394.89M1.15B962.29M1.04B
Accumulated Minority Interest -----
Total Equity 546.85M394.89M1.15B962.29M1.04B
Liabilities & Shareholders' Equity 661.98M553.23M1.6B1.4B1.46B
Link to MarketWatch's Slice.